Ghiasi Y, Wangberg H, Bagsic SRS, White A, et al. Type 2 biologics reduce cumulative steroid exposure in aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2022;129:642-643.
PMID: 35908738